127 related articles for article (PubMed ID: 10349696)
1. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV.
Dieterich DT; Purow JM; Rajapaksa R
Semin Liver Dis; 1999; 19 Suppl 1():87-94. PubMed ID: 10349696
[TBL] [Abstract][Full Text] [Related]
2. Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders.
Sauleda S; Juárez A; Esteban JI; Altisent C; Ruiz I; Puig L; Esteban R; Guardia J
Hepatology; 2001 Nov; 34(5):1035-40. PubMed ID: 11679976
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin.
Nasti G; Di Gennaro G; Tavio M; Cadorin L; Tedeschi RM; Talamini R; Carbone A; Tirelli U
AIDS; 2001 Sep; 15(14):1783-7. PubMed ID: 11579239
[TBL] [Abstract][Full Text] [Related]
4. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
Maddrey WC
Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.
McHutchison JG; Poynard T
Semin Liver Dis; 1999; 19 Suppl 1():57-65. PubMed ID: 10349693
[TBL] [Abstract][Full Text] [Related]
7. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C.
Davis GL
Semin Liver Dis; 1999; 19 Suppl 1():49-55. PubMed ID: 10349692
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
11. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
[TBL] [Abstract][Full Text] [Related]
12. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
Colson P; Bregigeon S; Tourres C; Solas C; Poizot-Martin I; Tamalet C
J Clin Virol; 2013 Sep; 58(1):309-14. PubMed ID: 23810614
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
14. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients.
Neary MP; Cort S; Bayliss MS; Ware JE
Semin Liver Dis; 1999; 19 Suppl 1():77-85. PubMed ID: 10349695
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
[TBL] [Abstract][Full Text] [Related]
16. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.
Coriat R; Podevin P
Int J STD AIDS; 2008 Mar; 19(3):208-10. PubMed ID: 18397566
[TBL] [Abstract][Full Text] [Related]
17. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients.
Dieterich DT
J Infect Dis; 2002 May; 185 Suppl 2():S128-37. PubMed ID: 12001034
[TBL] [Abstract][Full Text] [Related]
19. Standards of treatment in chronic hepatitis C.
Gish RG
Semin Liver Dis; 1999; 19 Suppl 1():35-47. PubMed ID: 10349691
[TBL] [Abstract][Full Text] [Related]
20. Blood transaminase elevation with pegylated interferon alfa 2b plus ribavirin in an HIV/HCV coinfected haemophilic patient.
Guitton E; Barange K; Bagheri H; Montastruc JL; Vinel JP; Claeyssens S; Bonnet E; Massip P
Infection; 2006 Jun; 34(3):183-5. PubMed ID: 16804666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
